In hepatoma HepG2 cells, miR-122 was strongly induced in cells treated with DNA methylation or histone deacetylase inhibitors via a direct binding of PPARγ/RXRα in the pre-miR-122 promoter [139]. Here, PPARG is linked to hepatocellular carcinoma.